Saratov Secures 145,650 Insulin Aspart Doses for 2026 Healthcare Plan
Saratov Secures 145,650 Insulin Aspart Doses for 2026 Healthcare Plan
Saratov Secures 145,650 Insulin Aspart Doses for 2026 Healthcare Plan
The Saratov Regional Health Ministry has announced a new procurement of insulin aspart for beneficiaries. The purchase is part of the 2026 regional state programme aimed at developing healthcare services. A total of 145,650 doses will be supplied under the contract. Each dose costs 119.68 rubles, bringing the total expenditure to 17.43 million rubles. The funds come from the regional budget allocated for the 'Healthcare Development' initiative.
The insulin will be delivered to the Saratov Pharmaceutical Warehouse. The supplier must complete the order by August 25, 2026. The procurement ensures a steady supply of insulin aspart for eligible patients in the region. The contract’s completion will mark a key step in the programme’s implementation for the year.
Octiv Explore transforms gym discovery for boutique fitness studios globally
Boutique gyms just got a digital boost. Octiv's latest tool turns its platform into a one-stop shop for fitness lovers—and a growth engine for studios.
German nursing care reform faces delay as health chief demands major revisions
A last-minute intervention could derail Germany's nursing care overhaul. Experts warn the current plan may burden taxpayers and pension funds for years.
Octiv Explore Transforms Gym Discovery for Boutique Fitness Studios Worldwide
Independent gyms just got a digital lifeline. Octiv's new feature turns its platform into a global fitness marketplace—no extra work required. The tool bridges the gap between studios and members, boosting visibility and bookings effortlessly.
German nursing care reform faces delay as DAK-Gesundheit demands major revisions
A last-minute push to halt the reform could reshape elderly care funding. Will the government listen—or risk a €1.8 billion pension crisis?